The Clinician and Pharmacist Question List
The safest conversation in sleep medicine is the one that happens before anything changes. This page is that conversation, written down: the questions to bring to a clinician and a pharmacist for a full medication and supplement review — what each thing is for, what it is doing besides sleeping, and how a change would be made if a change is warranted. No starting, stopping, or changing here. The list is the point.
What the evidence supports
- Medication review frameworks like STOPP/START and the AGS Beers Criteria catch potentially inappropriate prescribing when applied systematically (O'Mahony et al., Age and Ageing, 2015).
- Polypharmacy is common in exactly the group most affected by sleep aids: roughly 4 in 10 US adults 65 and older take five or more medications (Martin et al., NCHS, 2019).
- Deprescribing — a planned, supervised reduction — is a recognized clinical process with its own evidence base (Reeve et al., JAGS, 2015).
What remains uncertain
- How often a sleep aid is the right thing to stop versus adjust versus keep is a per-person judgment; no algorithm replaces the clinician.
- The long-term effects of many OTC sleep products are unmeasured, so the review conversation runs ahead of the data in both directions.
- Whether a given symptom — fatigue, memory, falls — is drug-related, sleep-related, or disease-related often takes a trial of supervision to answer.
Evidence last reviewed: August 20, 2026. Conclusions may change as new research is published.
questions worth asking
Why the List Exists
Most sleep-aid decisions are made without a review: a bottle from the shelf, a sample from a friend, a prescription continued for years past its original purpose. The professional counterweight is the medication review — the structured conversation that geriatrics and pharmacy have built over decades. The STOPP/START criteria and the AGS Beers Criteria exist because this exact conversation, done systematically, catches prescribing that harms more than it helps (O'Mahony et al., 2015; AGS, JAGS, 2023). The context is not hypothetical: about 4 in 10 US adults 65 and older take five or more medications (Martin et al., NCHS Data Brief, 2019), and sleep aids sit on top of that stack like the last plate in a tower. The quarterly audit topic treats the full-list review as a standing habit; this page is the sleep-specific version.
- 📋 The review is the evidence-backed intervention — criteria-based reviews are the tool with the track record; the questions below operationalize them.
- 🧱 Sleep aids ride on a stack — with 5+ medications common in older adults, the sleep product is rarely the whole story.
- 🛑 The rule that makes it safe — nothing changes during the conversation; the list is a map, and the map is not the road.
Product picks are generic categories, not brands. We may earn a commission on Amazon or iHerb purchases at no cost to you — this never changes our evidence conclusions. Full disclosure
Guided journal or notebook
Can support reflection, planning, or brief stress-management practices.
⚠️ Journaling may be distressing for some people; it is not a substitute for mental-health treatment or crisis support.
Check price on Amazon →The Complete Medication List, Rebuilt
The classic "brown bag" review — bring every bottle, including supplements — exists because the gaps are where the problems live. People routinely omit the PM pain reliever, the herbal tea with valerian, the magnesium gummy, the partner's leftover pill. Each omission is a blind spot for the pharmacist. The rebuilt list has five questions, and the Sleep Protocol series treats the rebuilt list as the starting point for every sleep conversation.
- 💊 What is this for, in one sentence? — if nobody can answer, that is the first finding of the review.
- 🧑⚕️ Who started it, and when? — a prescription from eight years ago and a prescription from last week carry different questions.
- ⏰ How much, at what time? — timing is where sleep aids and sedating drugs do most of their quiet damage.
- 🔁 Is it on the list twice? — diphenhydramine hides in cold formulas, PM pain relievers, and allergy pills; duplicates are a pharmacy specialty to catch.
- 🧴 Do the supplements get listed too? — the supplement shelf page explains why the bottle matters as much as the name.
The Sleep-Specific Questions
With the list rebuilt, the sleep lens narrows it. The goal is not to find something to cut — it is to understand what each item is doing at night, and what the morning after looks like:
- 🌙 Which of these affect sleep or wakefulness? — sedating antidepressants, hypnotics, stimulants, decongestants, and caffeine-bearing products all move the night.
- 🍷 What else is in the evening? — alcohol, cannabis, and late caffeine interact with every sedating item on the list; the alcohol calculus page runs the math.
- 🚗 How is the next day? — morning grogginess, near-misses while driving, and daytime dozing are adverse effects wearing ordinary clothes.
- 🦵 Is the sleep problem itself diagnosed? — apnea, restless legs, and periodic limb movement masquerade as "insomnia"; the sleep apnea page and the red-flag list are the screening half of this question.
The Condition Questions
The same drug is a different decision in a different body. Pregnancy and breastfeeding change the safety calculus of nearly every sleep product on the categories map. Kidney disease changes magnesium, lithium-adjacent clearance, and renally cleared sedatives. Liver disease changes the metabolism of many hypnotics and herbal extracts. And the sleep-apnea question belongs on every list: sedating anything on a background of untreated apnea is a different risk than sedation alone. The conditions below are the four the pharmacist will ask about first; volunteering them makes the visit faster and better.
- 🤰 Pregnancy or breastfeeding? — the answer rewrites the whole list; say it before the questions start.
- 🫘 Kidney or liver disease? — clearance changes dosing and safety for most of this shelf.
- 😮💨 Snoring, gasping, or daytime sleepiness? — untreated apnea plus any sedative is the highest-priority combination to surface.
- 🧠 Memory, falls, or confusion recently? — these are the anticholinergic and hypnotic warning signs the Beers Criteria exist to catch.
Five Questions for Any Sleep Aid
For each individual sleep product — prescription, OTC, or supplement — the same five questions apply. This is the table to carry in the pocket:
| Question | Why it matters | What to listen for |
|---|---|---|
| 💊 What is it for? | The purpose decides the review | "I don't remember" is a finding |
| ⏰ When and how much? | Timing and dose carry most of the risk | Higher-than-started doses signal tolerance |
| 🔁 How long have I taken it? | Duration separates acute from chronic use | Years-long nightly use needs a taper plan |
| ⚠️ What else is it doing? | Side effects hide as "getting older" | Falls, fog, dry mouth, constipation |
| 🛑 How would we change it? | The plan for stopping is part of the treatment | Abrupt stops can rebound; tapering is the norm |
How to Raise It at the Visit
The three-sentence frame that works in a short appointment: when it started, what changed, what you are asking. "This sleep aid started about a year ago, it stopped working two months back, and I'd like a plan for it — including how to stop if that is right." That gives the clinician a problem, a timeline, and a request in under thirty seconds, and it opens the door to the pharmacist for the dosing and interaction half of the conversation. Bring the list, bring the bottles, and write down the answers — the review is a working document, not a one-time chat.
- 🗣️ Three sentences open the door — start date, what changed, and the ask; the rest of the visit fills itself in.
- 🤝 The pharmacist is the second half — dosing, timing, interactions, and the OTC-shelf questions are their specialty; the melatonin and antihistamine pages prepare the questions.
- 📝 Write the plan down — including the "nothing changes yet" outcome; a documented review beats a remembered one.
⚠️ The boundary is absolute — this page never prescribes
No one on this site starts, stops, or changes a medication or supplement, and neither should you without professional guidance. Stopping a long-running hypnotic or benzodiazepine abruptly can trigger rebound insomnia, withdrawal, and — in some classes — seizures. Pregnancy, breastfeeding, kidney or liver disease, and polypharmacy change every answer on this page. The review is a conversation with a clinician and a pharmacist, full stop.
Questions, Answered Briefly
- ❓ Can I bring supplements to the pharmacist? — Please. The supplement shelf is exactly where the pharmacist adds the most value, checking forms, doses, and interactions the label never mentions.
- ❓ What if the clinician seems rushed? — Lead with the three-sentence frame and the written list; the review is the most efficient use of the visit, and the pharmacist visit can carry the rest.
- ❓ How often should the review happen? — A full review whenever anything changes, and at least annually — the same rhythm the quarterly audit builds for the rest of the health stack.
- ❓ What if I am worried about stopping something? — Say that worry out loud. Withdrawal risk is a professional planning problem with well-tested taper approaches; the wrong move is stopping quietly.
The Bottom Line
- The review is the intervention — criteria-based medication review is the evidence-backed tool; the questions here operationalize it for sleep.
- Rebuild the list first — every bottle, including supplements; the omissions are where the problems live.
- Ask the same five questions of every sleep aid — purpose, timing, duration, hidden effects, and the plan for changing it.
- Nothing changes during the conversation — the list is a map for the clinician and pharmacist, and the map is not the road.
Related Topics
- O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P, "STOPP/START criteria for potentially inappropriate prescribing in older people: version 2," Age and Ageing (2015)
- American Geriatrics Society 2023 Beers Criteria Update Expert Panel, "American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults," Journal of the American Geriatrics Society (2023)
- Martin CB, Hales CM, Gu Q, Ogden CL, "Prescription drug use in the United States, 2015–2016," NCHS Data Brief (2019)
- Chong Y, Fryar CD, Gu Q, "Prescription sleep aid use among adults: United States, 2005–2010," NCHS Data Brief (2013)
- Reeve E, Gnjidic D, Long J, Hilmer S, "A systematic review of the emerging definition of 'deprescribing' with network analysis," Journal of the American Geriatrics Society (2015)
- Watson NF, Badr MS, Belenky G, et al., "Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society," Sleep (2015)
- Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD, "Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians," Annals of Internal Medicine (2016)